Stay updated with breaking news from Lobe Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
"Our patent portfolio now consists of multiple patent filings for the use and delivery of psilocybin, psilocin analogues and N-Acetyl...
Vancouver, British Columbia--(Newsfile Corp. - July 19, 2022) - Lobe Sciences Ltd. (CSE: LOBE) (OTCQB: LOBEF) ("Lobe" or the "Company"), a Canadian Biopharmaceutical company committed to discovering and
At noon, as the Dow Jones added 1.73% to 31,609 points, the S&P 500 was up 1.56% to 3,902, and the Nasdaq jumped 2.18% to 11,608
4:22pm: Netflix stock climbs ahead of earnings report The Dow closed Tuesday up 754 points, 2.4%, at 31,827, the Nasdaq Composite jumped 353 points, 3.1% to...
4:22pm: Netflix stock climbs ahead of earnings report The Dow closed Tuesday up 754 points, 2.4%, at 31,827, the Nasdaq Composite jumped 353 points, 3.1% to...